Nutriband (NTRB) Stock Analysis
NASDAQHealthcareBiotechnology
What Nutriband does
Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.
Key metrics
ETFs linked to NTRB
Broad-market and Healthcare sector ETFs an investor holding Nutriband is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NTRB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NTRB in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Nutriband?
- Nutriband trades under the ticker NTRB on NASDAQ.
- Which exchange is NTRB listed on?
- NTRB is listed on NASDAQ.
- What sector does Nutriband operate in?
- Nutriband is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze NTRB in a portfolio?
- PortView shows NTRB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.